Overall survival with neoadjuvant nivolumab (NIVO) plus chemotherapy (chemo) in patients with resectable NSCLC in CheckMate 816 Meeting Abstract

  

Authors:	Forde, P. M.; Spicer, J.; Provencio, M.; Mitsudomi, T.; Awad, M. M.; Wang, C. L.; Lu, S.; Felip, E.; Broderick, S.; Swanson, S.; Brahmer, J. R.; Kerr, K.; Ciuleanu, T. E.; Tanaka, F.; Saylors, G. B.; Chen, K. N.; Wang, L.; Duong, Q.; Girard, N.
Abstract Title:	Overall survival with neoadjuvant nivolumab (NIVO) plus chemotherapy (chemo) in patients with resectable NSCLC in CheckMate 816
Meeting Title:	Journal of Clinical Oncology
Journal Title:	Journal of Clinical Oncology
Volume:	43
Issue:	17_SUPPL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2025-06-01
Language:	English
ACCESSION:	WOS:001525784200001
DOI:	10.1200/JCO.2025.43.17_suppl.LBA8000
PROVIDER:	wos
Notes:	Meeting Abstract -- 17_SUPPL -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/227865